CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt

• Asıl Yazarlar: Ahmed Shawky (Yazar), Hussein Sabit (Yazar), Mahmoud Nazih (Yazar), Khalid Baraka (Yazar), Mokhtar El-Zawahry (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Springer, 2023-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Cardiovascular diseases (CVDs) are considered a leading cause of death worldwide. Allelic variation in the CYP2C19 gene leads to a dysfunctional enzyme, and patients with this loss-of-function allele will have an impaired clopidogrel metabolism, which eventually results in major...